FDA recall D-297-2013

Hospira Inc. · Class II · drug

Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Reason for recall

Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2013-04-08
Report date
2013-05-01
Termination date
2014-11-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-297-2013